
Investors Targeted in Immutep Securities Class Action Lawsuit
Shareholders who bought Immutep Limited securities between March 24, 2025, and March 12, 2026, are being urged to join a class action lawsuit led by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding the efficacy of its TACTI-004 clinical trial.




















